Lv3
218 积分 2023-10-11 加入
Efficacy, safety, and predictive biomarkers of dalpiciclib combined with letrozole, pertuzumab and trastuzumab as neoadjuvant therapy in HR+/HER2+ breast cancer: A phase II study
1个月前
已关闭
Dual-lock gated DNAzyme-CRISPR cascade for amplification-free ultrasensitive profiling of FTO demethylase activity
1个月前
已完结
The interplay between oxytocin receptor and YAP in regulating gastric cancer progression
7个月前
已完结
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
7个月前
已完结
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
7个月前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
11个月前
已完结
皖公网安备34019202002308
